Chalcogen OCF 3 Isosteres Modulate Drug Properties without Introducing Inherent Liabilities - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue ChemMedChem Année : 2019

Chalcogen OCF 3 Isosteres Modulate Drug Properties without Introducing Inherent Liabilities

Clément Ghiazza
  • Fonction : Auteur
Callum Dickson
  • Fonction : Auteur
Anis Tlili
Christian Gampe
  • Fonction : Auteur

Résumé

The synthesis of SCF3 as well as SeCF3 isosteres of two OCF3-containing drugs was achieved through visible light and copper-catalyzed processes. Herein, we show that chalcogen replacement modulates physico-chemical and ADME properties without introducing intrinsic liabilities. The Sand SeCF3 groups are more lipophilic than their O-parent; however, microsomal stability is unchanged, indicating that these molecular changes may be beneficial for in vivo half-life. Enabled by modern synthetic methods, we present the chalcogen-CF3 groups as potential key players for future fluorinated pharmaceuticals.

Domaines

Chimie organique
Fichier principal
Vignette du fichier
Chalcogen OCF3 idhall.pdf (262.14 Ko) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-03035756 , version 1 (21-12-2020)

Identifiants

Citer

Clément Ghiazza, Thierry Billard, Callum Dickson, Anis Tlili, Christian Gampe. Chalcogen OCF 3 Isosteres Modulate Drug Properties without Introducing Inherent Liabilities. ChemMedChem, 2019, 14 (17), pp.1586-1589. ⟨10.1002/cmdc.201900452⟩. ⟨hal-03035756⟩
73 Consultations
299 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More